The latest update is out from HealthCare Global Enterprises Ltd. ( (IN:HCG) ).
HealthCare Global Enterprises Ltd. has announced the execution of significant transaction documents involving the sale of up to 54% of its diluted voting share capital from Aceso Company Pte. Ltd. to Hector Asia Holdings II Pte. Ltd. and KIA EBT II Scheme 1. This transaction includes a share purchase agreement, a termination agreement of a previous investment deal, and a promoter agreement. As part of this transaction, control of the company will shift to Purchaser 1, an affiliate of KKR & Co. Inc., with existing promoters stepping down from control roles. The changes signal a strategic shift in the company’s governance, potentially impacting its market operations and stakeholder relationships.
More about HealthCare Global Enterprises Ltd.
HealthCare Global Enterprises Ltd. operates in the healthcare sector, primarily focusing on oncology services. The company is known for providing specialized cancer care across various locations, positioning itself as a leader in cancer treatment and research.
YTD Price Performance: 2.95%
Average Trading Volume: 19,389
Current Market Cap: 69.7B INR
See more insights into HCG stock on TipRanks’ Stock Analysis page.